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Purpose: To examine radiologists’ screening performance in relation to 
the number of diagnostic work-ups performed after abnormal 
findings are discovered at screening mammography by the same 
radiologist or by different radiologists.
Materials and 
Methods:
In an institutional review board–approved HIPAA-compliant 
study, the authors linked 651 671 screening mammograms in-
terpreted from 2002 to 2006 by 96 radiologists in the Breast 
Cancer Surveillance Consortium to cancer registries (standard 
of reference) to evaluate the performance of screening mam-
mography (sensitivity, false-positive rate [FPR], and cancer 
detection rate [CDR]). Logistic regression was used to assess 
the association between the volume of recalled screening mam-
mograms (“own” mammograms, where the radiologist who in-
terpreted the diagnostic image was the same radiologist who 
had interpreted the screening image, and “any” mammograms, 
where the radiologist who interpreted the diagnostic image 
may or may not have been the radiologist who interpreted the 
screening image) and screening performance and whether the 
association between total annual volume and performance dif-
fered according to the volume of diagnostic work-up.
Results: Annually, 38% of radiologists performed the diagnostic work-up 
for 25 or fewer of their own recalled screening mammograms, 
24% performed the work-up for 0–50, and 39% performed the 
work-up for more than 50. For the work-up of recalled screen-
ing mammograms from any radiologist, 24% of radiologists per-
formed the work-up for 0–50 mammograms, 32% performed 
the work-up for 51–125, and 44% performed the work-up for 
more than 125. With increasing numbers of radiologist work-
ups for their own recalled mammograms, the sensitivity (P 
= .039), FPR (P = .004), and CDR (P , .001) of screening 
mammography increased, yielding a stepped increase in women 
recalled per cancer detected from 17.4 for 25 or fewer mam-
mograms to 24.6 for more than 50 mammograms. Increases in 
work-ups for any radiologist yielded significant increases in FPR 
(P = .011) and CDR (P = .001) and a nonsignificant increase in 
sensitivity (P = .15). Radiologists with a lower annual volume of 
any work-ups had consistently lower FPR, sensitivity, and CDR 
at all annual interpretive volumes.
Conclusion: These findings support the hypothesis that radiologists may im-
prove their screening performance by performing the diagnos-
tic work-up for their own recalled screening mammograms and 
directly receiving feedback afforded by means of the outcomes 
associated with their initial decision to recall. Arranging for 
radiologists to work up a minimum number of their own re-
called cases could improve screening performance but would 
need systems to facilitate this workflow.
q RSNA, 2014
Online supplemental material is available for this article.
Diana S. M. Buist, PhD, MPH
Melissa L. Anderson, MS
Robert A. Smith, PhD
Patricia A. Carney, PhD
Diana L. Miglioretti, PhD
Barbara S. Monsees, MD
Edward A. Sickles, MD
Stephen H. Taplin, MD, MPH
Berta M. Geller, EdD
Bonnie C. Yankaskas, PhD
Tracy L. Onega, PhD
effect of radiologists’ Diagnostic 
Work-up Volume on interpretive 
Performance1
Note: This copy is for your personal non-commercial use only. To order presentation-ready 
copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights.
BREAST IMAGING: Effect of Radiologists’ Diagnostic Work-up Volume on Interpretive Performance Buist et al
352 radiology.rsna.org n Radiology: Volume 273: Number 2—November 2014
radiologists the opportunity to enhance 
their interpretative skills by perform-
ing work-up for diagnostic images that 
result from recalled screening mammo-
grams interpreted by themselves or by 
other radiologists.
The purpose of this study was to 
to examine radiologists’ screening per-
formance in relation to the number of 
diagnostic examination work-ups after 
abnormal findings are discovered at 
screening mammography performed by 
the same radiologist or by different ra-
diologists. In addition, we determined 
whether work-up of abnormal screen-
ing mammograms modified the associ-
ation between annual interpretive vol-
ume and screening performance.
Materials and Methods
Subjects
The Breast Cancer Surveillance Con-
sortium (BCSC) registries and Statistical 
mammography performance and vol-
ume, although inconsistent, generally 
suggest that higher-volume readers have 
lower false-positive rates (FPRs); find-
ings on sensitivity are mixed (3). To ad-
dress these gaps between observed and 
optimal screening accuracy (1), previous 
studies examined the relationship be-
tween interpretive volume and screening 
and diagnostic performance (4,5).
Contrary to the hypothesis suggest-
ed by the Institute of Medicine report 
that a higher interpretive volume would 
improve mammography performance, 
a study of a sample of U.S. radiologists 
found that volume did not explain much 
of the observed interradiologist variabil-
ity in screening or diagnostic perfor-
mance (4,5). The FPRs of radiologists 
with higher annual volumes were clini-
cally and significantly lower than those 
of their lower-volume colleagues; how-
ever, the sensitivities were similar (4,5). 
Interpretive volume composition (ratio 
of screening volume relative to total 
volume) had the strongest influence on 
screening and diagnostic performance; a 
higher screening focus (ratio of screen-
ing to diagnostic mammograms) was as-
sociated with significantly lower screen-
ing sensitivity, cancer detection rate 
(CDR), and FPR (4,5), which suggests 
that having some element of diagnostic 
work-up could increase sensitivity and 
CDR. To our knowledge, only one study 
has examined whether radiologists’ ac-
curacy (defined as positive predictive 
value for biopsy recommendation) was 
influenced by monitoring a woman’s im-
ages throughout the diagnostic process 
and found no significant influence (6). 
These findings indicate that interpretive 
volume alone is not the principal influ-
ence on performance; rather, volume 
might affect performance by allowing 
Published online before print
10.1148/radiol.14132806 Content code: 
Radiology 2014; 273:351–364
Abbreviations:
BCSC = Breast Cancer Surveillance Consortium
BI-RADS = Breast Imaging Reporting and Data System
CDR = cancer detection rate
CI = confidence interval
DCIS = ductal carcinoma in situ
FPR = false-positive rate
Author contributions:
Guarantors of integrity of entire study, D.S.M.B., T.L.O.; 
study concepts/study design or data acquisition or data 
analysis/interpretation, all authors; manuscript drafting 
or manuscript revision for important intellectual content, 
all authors; manuscript final version approval, all authors; 
literature research, D.S.M.B., R.A.S., T.L.O.; clinical studies, 
D.S.M.B., D.L.M., B.C.Y., T.L.O.; experimental studies, 
D.S.M.B., B.S.M.; statistical analysis, D.S.M.B., M.L.A., 
R.A.S., T.L.O.; and manuscript editing, all authors
Funding:
This research was supported by the National Cancer Insti-
tute Breast Cancer Surveillance Consortium (U01CA63740, 
U01CA86076, U01CA86082, U01CA70013, U01CA69976, 
U01CA63731, U01CA63736, U01CA70040, HH-
SN261201100031C). Portions of the data collection were 
supported by the National Cancer Institute and Agency for 
Healthcare Research and Quality (R01 CA107623) and the 
National Cancer Institute (K05 CA104699).
Conflicts of interest are listed at the end of this article.
Advances in Knowledge
 n Radiologists who interpreted a 
greater annual number of diag-
nostic mammograms that 
resulted from recall of screening 
mammograms they interpreted 
had consistently higher sensi-
tivity (81.1% for 0–25 mammo-
grams to 87.0% for .50 mam-
mograms, P = .039) and cancer 
detection rates (CDRs) (3.1 per 
1000 screening mammograms for 
0–25 mammograms to 4.5 per 
1000 screening mammograms for 
.50 mammograms, P , .001) 
than radiologists who interpreted 
fewer of these mammograms; 
however, the false-positive rate 
(FPR) was higher (6.7% for 0–25 
mammograms to 10.3% for .50 
mammograms, P = .004).
 n These performance changes 
resulted in a stepped increase in 
the number of women recalled 
per cancer detected, ranging 
from 17.4 for radiologists who 
interpreted 25 or fewer of their 
recalled mammograms per year 
to 24.6 for radiologists who 
interpreted more than 50 of their 
recalled mammograms per year.
 n Radiologists with a lower annual 
number of work-ups of recalled 
screening mammograms (0–50 
mammograms vs .125 mammo-
grams) had consistently lower 
FPRs (7.0% vs 10.3%, P = .15), 
sensitivity (80.8% vs 86.5%, P = 
.011), and CDRs (2.9 per 1000 vs 
4.4 per 1000, P = .001) at all 
annual interpretive volumes.
Implication for Patient Care
 n Arranging for radiologists to per-
form a minimum number of diag-
nostic work-ups that resulted 
from recall of screening mammo-
grams they interpreted could 
improve screening mammography 
performance in the United 
States.
A 2005 Institute of Medicine re-port (1) noted that the technical quality of mammography has im-
proved since the 1992 Mammography 
Quality Standards Act but that optimal 
sensitivity and specificity have not been 
achieved—a conclusion reinforced by 
recent investigations (2). The Institute 
of Medicine report called for additional 
research on the relationship between 
interpretive volume and performance 
(1). Results on the association between 
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Coordinating Center received institu-
tional review board approval for active 
or passive consenting processes and a 
Federal Certificate of Confidentiality 
and other protections for participating 
women, physicians, and facilities. All 
procedures were compliant with the 
Health Insurance Portability and Ac-
countability Act (7).
Data Collection
BCSC registries collect information 
about mammography performed at par-
ticipating facilities in their defined catch-
ment areas and link this information to 
state tumor registries or regional Sur-
veillance Epidemiology and End Results 
programs to obtain population-based 
cancer data (8,9). Demographic and 
breast cancer risk factor data, including 
age, first-degree family history, and time 
since last mammographic examination, 
are collected with use of a self-report-
ed questionnaire completed at each 
screening mammography examination. 
This study included data from six BCSC 
mammography registries (in California, 
North Carolina, New Hampshire, Ver-
mont, Washington, and New Mexico). 
Because planned analysis required 
complete capture of all screening and 
diagnostic images for each radiologist, 
we limited our sample to radiologists 
who interpreted mammograms only in 
BCSC facilities (436 reader-years, 106 
radiologists) (4,5). Eligible radiologists 
from the six registries who interpreted 
screening mammograms from 2005 to 
2006 were invited to complete a self-ad-
ministered mailed survey between Janu-
ary 1, 2006, and September 30, 2007 
(10), and survey information was linked 
to BCSC data. We excluded 10 radiolo-
gists (43 reader-years) who interpreted 
mammograms at facilities with incom-
plete BCSC data on diagnostic mam-
mograms during the study years. The 
radiologists and reader-years included 
in these analyses are a subset of those 
previously reported (5).
The two primary exposures of in-
terest were “own” work-ups and “any” 
work-ups. The measurement of “own” 
started at a recalled screening exami-
nation and determined the number of 
those recalled screening mammograms 
with a diagnostic work-up (mammog-
raphy with or without ultrasonography 
[US], counted as one examination) 
within 60 days (11) interpreted by 
the same radiologist who recalled the 
screening mammogram. The measure-
ment of “any” started with the interpre-
tation of any diagnostic mammogram 
(with or without US, counted as one 
examination), regardless of which radi-
ologist recalled the screening mammo-
gram. We followed the Breast Imaging 
Reporting and Data System (BI-RADS) 
lexicon and collected one overall as-
sessment for diagnostic examinations 
with or without US (12,13). Because 
any work-ups included all diagnostic 
mammograms obtained for work-up of 
a positive screening examination, unlike 
the own work-ups, we did not require 
linkage to the recalled screening exam-
ination or that the diagnostic work-up 
be performed within 60 days of the 
screening examination. The two expo-
sure measures overlap. For example, a 
work-up would be counted as both own 
and any if the same radiologist recalled 
the screening mammogram and inter-
preted the diagnostic follow-up mam-
mogram within 60 days of the screening 
examination. Therefore, most diagnos-
tic follow-up mammograms classified 
as own work-ups were also included as 
any work-ups (except when the only di-
agnostic follow-up was US).
Annual interpretive volume for 
2001–2005 was collected and summed 
across all facilities for total, screening, 
and diagnostic volumes. Examination 
type was defined by using radiologists’ 
indications for examinations (5). Diag-
nostic examinations included additional 
evaluation of a previous abnormal 
screening mammogram, short-interval 
follow-up, or evaluation of a breast 
symptom or mammographic abnormal-
ity with or without US.
Screening performance was based 
on the radiologist’s initial assessment 
(positive or negative) of the screen-
ing mammogram linked to invasive 
carcinoma or ductal carcinoma in situ 
(DCIS) diagnoses collected from tumor 
registries and pathology databases and 
diagnosed within the follow-up period 
(1 year after the screening mammogram 
and before the next screening mammog-
raphy examination) (13). Registry data 
were used to characterize the tumors 
with regard to histologic characteristic 
(DCIS vs invasive), stage (0–IV), tumor 
size, axillary lymph node involvement 
(negative or positive), grade (well dif-
ferentiated to undifferentiated), and 
estrogen receptor status. We defined 
minimal detected and early stage can-
cers in three ways, as follows: (a) DCIS 
or invasive cancer 10 mm or smaller 
(12), (b) DCIS or invasive cancer small-
er than 15 mm and node negative (4,5), 
or (c) DCIS or invasive cancer 10 mm 
or smaller and node negative (4,5).
Performance measures (sensi-
tivity, FPR, and CDR) were derived 
from 651 671 screening mammograms 
(404 538 unique women, asymptomatic 
subjects with routine screening indi-
cation) interpreted from 2002 to 2006 
by using standard BI-RADS and BCSC 
definitions (5). The mammograms and 
unique women reported herein are a 
subset of those previously reported (5). 
Sensitivity was defined as the proportion 
of screening mammograms interpreted 
as positive (defined as BI-RADS cate-
gories 0 [needs additional assessment], 
4 [suspicious abnormality], 5 [highly 
suggestive of malignancy], or 3 [proba-
bly benign when associated with a rec-
ommendation for immediate follow-up, 
ie, more imaging, clinical examination, 
biopsy]) (12) diagnosed within the fol-
low-up period. The FPR was defined as 
the proportion of positive screening ex-
aminations among all women without a 
breast cancer diagnosis within the fol-
low-up period. The CDR was defined as 
the number of cancers detected within 
the follow-up period per 1000 screening 
mammograms interpreted.
Statistical Analysis
The two work-up volume measures 
(own and any) and annual total inter-
pretive volume measures for each year 
were linked to screening performance 
in the following year (eg, 2005 volume 
was linked to 2006 performance). The 
Pearson correlation coefficient was 
used to estimate the strength of the 
linear relationship between the con-
tinuous measures of work-up volume. 
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time (76%), had at least 20 years of 
experience (53%), and did not have 
fellowship training in breast imag-
ing (95%) (Table 1). Time spent on 
breast imaging varied and was less 
than 20% for 24% of radiologists and 
80%–100% for 32%. Thirty-eight per-
cent of radiologists worked up 25 or 
fewer of their own recalled screening 
mammograms a year, 24% worked up 
0–50, and 39% worked up more than 
50. Twenty-four percent of radiolo-
gists worked up 0–50 of any recalled 
screening mammograms, 32% worked 
up 51–125, and 44% worked up more 
than 125.
Radiologists who performed work-
up for a greater number of own or any 
recalled screening mammograms were 
more likely to have completed fellow-
ship training, have greater annual inter-
pretive volumes, and spend more than 
40% of their time on breast imaging 
(Table 1). Associations between work-
ing up own and any recalled mammo-
grams with volume (total and diagnos-
tic) were similar, with higher-volume 
readers interpreting more own and any 
recalled screening mammograms. The 
work-up of own and any mammograms 
showed a positive correlation (Pearson 
correlation coefficient = 0.49, P , .01) 
(Fig E1 [online]).
The low-, medium-, and high-vol-
ume categories for the work-up of own 
recalled mammograms included 25%, 
21%, and 53% of the screening mam-
mograms used to calculate screening 
performance; the low-, medium-, and 
high-volume categories for the work-
up of any recalled mammograms in-
cluded 13%, 27%, and 60% of the 
screening mammograms used to calcu-
late screening performance (Table 2). 
The characteristics of the women ac-
cording to age, first-degree family his-
tory, or time since last mammographic 
examination did not differ according to 
low-, medium-, or high-volume category 
for either exposure measure (ie, own 
or any work-up). Most screening mam-
mograms included in the performance 
outcome measures were obtained in 
women aged 40–59 years (60%), with 
3% obtained in women younger than 
40 years and 5% in women aged at 
same radiologist. Because the diagnostic 
work-up measures were heavily skewed 
with sparse data in high volumes, we 
restricted the range before fitting the 
models to ensure stable estimates of 
model parameters; therefore, model es-
timation excluded outliers (radiologists 
with .250 own and .600 any recalled 
mammograms). Model results are pre-
sented graphically with 95% confidence 
intervals (CIs), with the curves inter-
preted directly as the mean adjusted 
performance as a function of the expo-
sure measure. P values for the estimated 
curves correspond to omnibus tests of 
whether there is any relationship be-
tween mean adjusted performance and 
work-up volume.
Similar methods were used to test 
the hypothesis that the relationship 
between total interpretive volume and 
screening performance is different for 
radiologists with low versus high vol-
umes of diagnostic work-ups. Logistic 
regression models with cubic smoothing 
splines were used to estimate perfor-
mance as a function of total interpretive 
volume. We restricted the range of total 
volume to 6000 or fewer mammograms 
because of sparse data in the tails. In-
teraction terms were included in the 
model to estimate separate curves for 
low and high levels of diagnostic work-
up. P values correspond to omnibus 
tests of whether there is a difference in 
the shape (interaction term to assess ef-
fect modification) of the volume-perfor-
mance relationship for radiologists with 
low versus high volumes of work-ups 
of recalled screening mammograms. 
Model results are presented graphically, 
with separate curves for low and high 
diagnostic work-up volume; the curves 
are the mean adjusted performance as 
a function of the total annual volume.
Statistical analyses were performed 
with software (SAS version 9.2, SAS 
Institute, Cary, NC [16], and Stata ver-
sion 12.0, StataCorp, College Station, 
Tex [17]).
Results
The 96 radiologists in the study had a 
median age of 53 years (range, 37–72 
years). Most radiologists worked full 
Two breast imaging specialists (E.A.S. 
and B.S.M., with 38 and 34 years of 
experience, respectively) evaluated the 
data with all coauthors to assess feasi-
bility for measurement and implemen-
tation and classified volumes as low 
(,25 mammograms), medium (26–50 
mammograms), and high (.50 mam-
mograms) and any work-up into low 
(,50 mammograms), medium (51–125 
mammograms), and high (.125 mam-
mograms). We calculated unadjusted 
screening performance by using these 
categoric volume diagnostic work-
up measures. To assess the potential 
trade-off between sensitivity and FPR, 
we calculated the number of women re-
called for each cancer detected. All P 
values are two sided.
Because a radiologist’s case-mix 
distribution (average age and screening 
intervals) might have an effect on results, 
we computed adjusted performance 
measures by using internal standardiza-
tion (14) to account for differences in 
radiologists’ case-mix distributions (5). 
Internal standardization works by re-
weighting mammograms according to 
the relative difference between the ra-
diologist’s specific distribution of poten-
tial confounders (age and time since last 
mammography examination) and the 
corresponding distribution in the over-
all analytic sample. This process enables 
calculation of performance measures for 
radiologists as if their case mixes were 
the same as that in the overall popula-
tion. To assess the relationship between 
the continuous work-up measures and 
adjusted performance, we stratified ac-
cording to cancer status, fitting separate 
models for each performance measure 
by using the radiologist’s initial mammo-
graphic assessment (positive or negative) 
as the binary outcome variable. Contin-
uous diagnostic work-up measures were 
included in the regression models by 
using restricted cubic smoothing splines 
(15) to allow for nonlinearity and to per-
mit a flexible shape for the relationship 
between the continuous volume measure 
and interpretive performance. We fit lo-
gistic models by using generalized esti-
mating equations with robust standard 
errors to account for correlation be-
tween multiple observations from the 
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Table 1




Average Annual Work-up of Own  
Recalled Mammograms




















Average annual work-up of own  
  recalled mammograms
 0–25 mammograms 36 (38) … … … 13 (57) 15 (48) 8 (19)
 26–50 mammograms 23 (24) … … … 5 (22) 5 (16) 13 (31)
 .50 mammograms 37 (39) … … … 5 (22) 11 (35) 21 (50)
Average annual work-up of any  
  recalled mammograms
 0–50 mammograms 23 (24) 13 (36) 5 (22) 5 (14) … … …
 51–125 mammograms 31 (32) 15 (42) 5 (22) 11 (30) … … …
 .125 mammograms 42 (44) 8 (22) 13 (57) 21 (57) … … …
Age at survey
 ,45 y 24 (25) 10 (28) 5 (22) 9 (24) 7 (30) 9 (29) 8 (19)
 45–54 y 29 (30) 10 (28) 7 (30) 12 (32) 4 (17) 6 (19) 19 (45)
 55 y 43 (45) 16 (44) 11 (48) 16 (43) 12 (52) 16 (52) 15 (36)
Sex
 M 65 (68) 26 (72) 16 (70) 23 (62) 19 (83) 24 (77) 22 (52)
 F 31 (32) 10 (28) 7 (30) 14 (38) 4 (17) 7 (23) 20 (48)
Works full time (40 h/wk)
 No 23 (24) 6 (17) 8 (36) 9 (25) 6 (26) 4 (13) 13 (32)
 Yes 71 (76) 30 (83) 14 (64) 27 (75) 17 (74) 26 (87) 28 (68)
Primary affiliation with academic  
  medical center
 No affiliation 69 (73) 27 (75) 16 (70) 26 (73) 16 (70) 23 (74) 30 (73)
 Adjunct 7 (7) 2 (6) 2 (9) 3 (8) 1 (4) 2 (6) 4 (10)
 Primary 19 (20) 7 (19) 5 (22) 7 (19) 6 (26) 6 (19) 7 (17)
Experience
 Years since graduated residency
  ,10 15 (16) 8 (22) 3 (13) 4 (11) 3 (13) 8 (26) 4 (10)
  10–19 30 (32) 11 (31) 8 (35) 11 (31) 5 (22) 9 (29) 16 (39)
  20 50 (53) 17 (47) 12 (52) 21 (58) 15 (65) 14 (45) 21 (51)
 Combined variable of fellowship  
  training and years of experience  
  in mammography interpretation
  No fellowship, ,10 y 17 (18) 9 (25) 3 (13) 5 (14) 5 (22) 6 (19) 6 (14)
  No fellowship, 10–19 y 32 (33) 12 (33) 9 (39) 11 (30) 2 (9) 14 (45) 16 (38)
  No fellowship, 20 y 42 (44) 15 (42) 11 (48) 16 (43) 15 (65) 11 (36) 16 (38)
  Fellowship, ,10 y 1 (1) 0 (0) 0 (0) 1 (3) 0 (0) 0 (0) 1 (2)
  Fellowship, 10 y 4 (4) 0 (0) 0 (0) 4 (11) 1 (4) 0 (0) 3 (7)
 Time working in breast imaging
  ,20% 22 (24) 11 (31) 3 (14) 8 (23) 7 (33) 10 (34) 5 (12)
  20%–39% 25 (27) 10 (29) 10 (45) 5 (14) 3 (14) 12 (41) 10 (24)
  40%–79% 16 (17) 3 (9) 4 (18) 9 (26) 3 (14) 3 (10) 10 (24)
  80%–100% 29 (32) 11 (31) 5 (23) 13 (37) 8 (38) 4 (14) 17 (40)
Interpretive volume
 Average annual total volume
  480–999 mammograms 16 (17) 12 (33) 2 (9) 2 (5) 10 (43) 5 (16) 1 (2)
Table 1 (continues)
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Average Annual Work-up of Own  
Recalled Mammograms




















  1000–1499 mammograms 20 (21) 9 (25) 4 (17) 7 (19) 7 (30) 9 (29) 4 (10)
  1500–1999 mammograms 16 (17) 7 (19) 5 (22) 4 (11) 4 (17) 5 (16) 7 (17)
  2000–2999 mammograms 23 (24) 6 (17) 9 (39) 8 (22) 0 (0) 9 (29) 14 (33)
  3000–4999 mammograms 12 (13) 1 (3) 2 (9) 9 (24) 2 (9) 2 (6) 8 (19)
  5000 mammograms 9 (9) 1 (3) 1 (4) 7 (19) 0 (0) 1 (3) 8 (19)
 Average annual screening volume
  480–999 mammograms 24 (25) 16 (44) 3 (13) 5 (14) 13 (57) 7 (23) 4 (10)
  1000–1499 mammograms 17 (18) 6 (17) 5 (22) 6 (16) 4 (17) 9 (29) 4 (10)
  1500–1999 mammograms 26 (27) 9 (25) 10 (43) 7 (19) 4 (17) 9 (29) 13 (31)
  2000–2999 mammograms 13 (14) 3 (8) 4 (17) 6 (16) 1 (4) 3 (10) 9 (21)
  3000 mammograms 16 (17) 2 (6) 1 (4) 13 (35) 1 (4) 3 (10) 12 (29)
 Average annual diagnostic volume
  ,100 mammograms 11 (11) 9 (25) 2 (9) 0 (0) 11 (48) 0 (0) 0 (0)
  100–199 mammograms 11 (11) 6 (17) 3 (13) 2 (5) 5 (22) 6 (19) 0 (0)
  200–299 mammograms 24 (25) 11 (31) 3 (13) 10 (27) 6 (26) 13 (42) 5 (12)
  300–499 mammograms 33 (34) 10 (28) 13 (57) 10 (27) 1 (4) 12 (39) 20 (48)
  500–999 mammograms 8 (8) 0 (0) 1 (4) 7 (19) 0 (0) 0 (0) 8 (19)
  1000 mammograms 9 (9) 0 (0) 1 (4) 8 (22) 0 (0) 0 (0) 9 (21)
 Average annual percentage of  
  examinations that are  
  screening examinations
  ,75% 6 (6) 2 (6) 1 (4) 3 (8) 0 (0) 1 (3) 5 (12)
  75%–79% 13 (14) 3 (8) 4 (17) 6 (16) 0 (0) 2 (6) 11 (26)
  80%–84% 35 (36) 13 (36) 9 (39) 13 (35) 1 (4) 14 (45) 20 (48)
  85%–89% 21 (22) 6 (17) 5 (22) 10 (27) 8 (35) 7 (23) 6 (14)
  90% 21 (22) 12 (33) 4 (17) 5 (14) 14 (61) 7 (23) 0 (0)
 Average annual number of  
  facilities where interpreting
  1 31 (32) 8 (22) 6 (26) 17 (46) 9 (39) 15 (48) 7 (17)
  .1 to 2 39 (41) 15 (42) 11 (48) 13 (35) 11 (48) 10 (32) 18 (43)
  .2 to 3 16 (17) 8 (22) 4 (17) 4 (11) 3 (13) 6 (19) 7 (17)
  .3 10 (10) 5 (14) 2 (9) 3 (8) 0 (0) 0 (0) 10 (24)
Note.—Data are numbers of radiologists, with column percentages in parentheses.
Table 1 (continued)
Characteristics of Radiologists according to Average Annual Volume of Work-up of Own and Any Recalled Screening Mammograms
least 80 years. The characteristics of 
women who had their mammograms 
interpreted at academic medical cen-
ters were not different from those of 
women whose mammograms were 
interpreted at nonacademic facilities 
(Table E1 [online]).
There were 3101 cancers in the 
study population; 2646 were detected 
with screening mammography. Among 
invasive cancers, stage distribution and 
median tumor size did not vary accord-
ing to either exposure measure (own or 
any work-up) (Table 3). Of 455 interval-
detected cancers, 89% were invasive 
cancers with a larger median size (19 
mm) and a higher fraction (25%) were 
estrogen receptor–negative compared 
with screening-detected cancers (Table 
E2 [online]).
The unadjusted mean sensitivity 
was 85.3% (95% CI: 83.6%, 86.9%), 
the FPR was 9.1% (95% CI: 8.0%, 
10.3%), and the CDR was 4.1 per 1000 
screening mammograms (95% CI: 3.7, 
4.5) (Table 4). As the number of own 
work-ups increased, the adjusted sen-
sitivity, FPR, and CDR significantly 
increased (Fig 1), yielding a stepped 
increase in the number of women re-
called per cancer detected from 17.4 
for 25 or fewer mammograms to 24.6 
for more than 50 mammograms (Table 
4). Improved sensitivity and CDR were 
accompanied by an increase in the FPR 
with each category of own work-ups, 
which was consistent with the figures 
showing little improvement for volumes 
of more than 50 own work-ups or more 
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than 125 any work-ups (Fig 2). The one 
exception was CDR, where CDR was 
significantly (P = .039) reduced with in-
creasing annual volume for radiologists 
who interpreted fewer than 50 of their 
own recalled mammograms.
Unadjusted sensitivity increased 
from 80.8% for radiologists with 50 
or fewer any work-ups to 86.5% for 
those with more than 125 any work-ups 
(Table 4); however, the association be-
tween adjusted sensitivity and volume 
of any work-up was not significant (P = 
.15) (Fig 1d). An increase in the volume 
of any work-up yielded statistically sig-
nificant increases in the FPR and CDR 
(Fig 1e, 1f).
Overall, 22.2 women out of 1000 
were recalled for each cancer detect-
ed. The lowest number of women re-
called per cancer detected was among 
radiologists who worked up the few-
est numbers of own and any recalled 
mammograms; however, these radiol-
ogists also had the lowest sensitivity. 
Radiologists with the highest sensitiv-
ity and CDR and the lowest FPR had 
worked up more than 25 of own re-
called mammograms or more than 50 
of any recalled mammograms.
In general, the shape of the relation-
ship between total interpretive volume 
and screening performance did not differ 
according to a low versus high volume of 
diagnostic follow-up (Fig 2). However, 
readers with fewer own or any work-ups 
had consistently lower sensitivity, FPR, 
and CDR at any given total volume. The 
stratified analysis also showed decreased 
FPRs with increasing total annual volume 
to a threshold of 2000.
Discussion
We found that radiologists with a 
higher annual volume of work-ups for 
recalled screening mammograms they 
initially interpreted had consistently 
higher screening sensitivities and 
CDRs; however, these performance 
improvements were accompanied 
by higher FPRs. We expected that 
a higher volume of diagnostic work-
ups for a radiologist who interpreted 
the screening mammogram would be 
associated with better screening per-
formance because of the radiologist’s 
involvement throughout a case, pos-
sibly including interventional proce-
dures (18,19). This constitutes direct 
feedback on the radiologist’s clinical 
decisions. Performing analysis with 
continuous measures and accounting 
for potential confounders resulted in 
improved sensitivity for radiologists 
who annually work up diagnostic ex-
aminations resulting from at least 50 
of their own recalled mammograms 
and a higher CDR for radiologists who 
Table 2
Characteristics of Women Whose Mammograms Were Used to Calculate Screening Performance Measures according to Annual 
Volume of Own and Any Recalled Screening Mammograms
Parameter Total (n = 651 671)
Average Annual Volume of Own  
Recalled Mammograms




(n = 164 834)
26–50  
Mammograms  
(n = 139 244)
.50  
Mammograms  
(n = 347 593)
0–50 
Mammograms  
(n = 83 326)
51–125  
Mammograms  
(n = 178 766)
.125 
Mammograms  
(n = 389 579)
Age at screening  
 mammography
 ,40 y 19 734 (3) 5291 (3) 3566 (3) 10 877 (3) 2951 (4) 5584 (3) 11 199 (3)
 40–49 y 183 967 (28) 46 148 (28) 38 422 (28) 99 397 (29) 24 258 (29) 48 034 (27) 111 675 (29)
 50–59 y 205 916 (32) 51 849 (32) 45 142 (32) 108 925 (31) 25 531 (31) 55 102 (31) 125 283 (32)
 60–69 y 128 089 (20) 33 003 (20) 27 304 (20) 67 782 (20) 15 998 (19) 37 665 (21) 74 426 (19)
 70–79 y 83 566 (13) 21 250 (13) 18 137 (13) 44 179 (13) 10 854 (13) 24 410 (14) 48 302 (12)
 80 y 30 399 (5) 7293 (4) 6673 (5) 16 433 (5) 3734 (4) 7971 (4) 18 694 (5)
First-degree family history 
 No 487 338 (84) 129 070 (78) 94 037 (68) 264 231 (76) 57 378 (69) 143 974 (81) 285 986 (73)
 Yes 95 606 (16) 23 315 (14) 20 792 (15) 51 499 (15) 11 047 (13) 24 447 (14) 60 112 (15)
 Unknown 68 727 [11] 12 449 [8] 24 415 [17] 31 863 [9] 14 901 [18] 10 345 [6] 43 481 [11]
Time since last  
 mammography
 No previous  
 mammography
28 267 (5) 7379 (5) 6526 (5) 14 362 (4) 4045 (5) 8709 (5) 15 513 (4)
 ,2 y 529 614 (85) 114 178 (81) 114 178 (82) 281 802 (81) 67 988 (82) 142 019 (79) 319 607 (82)
 3–4 y 39 880 (6) 8771 (6) 8771 (6) 20 615 (6) 5552 (7) 11 743 (7) 22 585 (6)
 5 y 22 975 (4) 5032 (4) 5032 (4) 11 792 (3) 3086 (4) 6789 (4) 13 100 (3)
 Unknown 30 935 [5] 4737 [4] 4737 [3] 19 022 [6] 2655 [3] 9506 [5] 18 774 [5]
Note.—Data are numbers of women, with column percentages in parentheses. Percentages in brackets (for unknown variables) were not included in total column percentages. 
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Table 3




Average Annual Volume of Own Recalled  
Screening Mammograms



















(n = 1742 
Cancer histologic type
 DCIS 681 (26) 119 (25) 149 (24) 413 (26) 72 (29) 151 (23) 458 (26)
 All invasive 1961 (74) 348 (75) 460 (76) 1153 (74) 178 (71) 501 (77) 1282 (74)
 Unknown 4 [0] 0 [0] 2 [0] 2 [0] 1 [0] 1 [0] 2 [0]
Stage
 0 681 (27) 119 (27) 149 (25) 413 (28) 72 (30) 151 (25) 458 (27)
 I 1151 (45) 208 (46) 290 (49) 653 (44) 102 (43) 272 (45) 777 (46)
 II 558 (22) 97 (22) 127 (21) 334 (22) 41 (17) 136 (22) 381 (23)
 III 136 (5) 20 (4) 30 (5) 86 (6) 22 (9) 42 (7) 72 (4)
 IV 16 (1) 4 (1) 1 (0) 11 (1) 1 (0) 10 (2) 5 (0)
 Unknown 104 (4) 19 (4) 14 (2) 71 (5) 13 (5) 42 (6) 49 (3)
Cancer size*
 5 mm 222 (12) 37 (11) 55 (12) 130 (12) 20 (12) 51 (11) 151 (12)
 6–10 mm 463 (25) 83 (25) 119 (27) 261 (24) 33 (20) 101 (22) 329 (26)
 11–15 mm 484 (26) 83 (25) 133 (30) 268 (25) 49 (30) 115 (25) 320 (26)
 16–20 mm 274 (15) 66 (20) 49 (11) 159 (15) 25 (15) 90 (19) 159 (13)
 .20 mm 430 (23) 65 (19) 89 (20) 276 (25) 36 (22) 111 (24) 283 (23)
 Unknown 88 [4] 14 [4] 15 [3] 59 [5] 15 [8] 33 [7] 40 [3]
Median cancer size* 13 14 12 13 14 15 13
Minimal cancer† 
 DCIS or invasive cancer 10 mm 1366 (53) 239 (53) 323 (54) 804 (53) 125 (53) 303 (49) 938 (55)
 Invasive cancer .10 mm 1188 (47) 214 (47) 271 (46) 703 (47) 110 (47) 316 (51) 762 (45)
 Unknown 92 [3] 14 [3] 17 [3] 61 [4] 16 [6] 34 [5] 42 [2]
Early stage at diagnosis (definition 1)
 DCIS or invasive cancer  
 ,15 mm + node negative 
1554 (61) 263 (58) 380 (64) 911 (61) 151 (64) 344 (55) 1059 (63)
 Other 991 (39) 187 (42) 216 (36) 588 (39) 84 (36) 278 (45) 629 (37)
 Unknown 101 [4] 17 [4] 15 [2] 69 [4] 16 [6] 31 [4] 54 [3]
Early stage at diagnosis (definition 2)
 DCIS or invasive cancer  
 10 mm + node negative 
1282 (50) 221 (49) 304 (51) 757 (50) 121 (51) 282 (45) 879 (52)
 Other 1265 (50) 230 (51) 292 (49) 743 (50) 114 (49) 342 (55) 809 (48)
 Unknown 99 [4] 16 [3] 15 [2] 68 [4] 16 [6] 29 [5] 54 [3]
Axillary lymph node status*
 Negative 1441 (76) 242 (72) 349 (77) 850 (76) 133 (80) 350 (72) 958 (77)
 Positive 467 (24) 95 (28) 103 (23) 269 (24) 34 (20) 139 (28) 294 (23)
 Unknown 53 [3] 11 [3] 8 [2] 34 [3] 11 [6] 12 [2] 30 [2]
Grade*
 1 (well differentiated) 464 (26) 89 (28) 112 (26) 263 (25) 41 (28) 106 (24) 317 (27)
 2 (moderately differentiated) 802 (45) 142 (45) 199 (47) 461 (44) 63 (42) 201 (45) 538 (45)
 3 (poorly differentiated) 508 (28) 82 (26) 115 (27) 311 (30) 45 (30) 138 (31) 325 (27)
 4 (undifferentiated) 19 (1) 2 (1) 1 (0) 16 (2) 0 (0) 3 (1) 16 (1)
 Unknown 168 [9] 33 [9] 33 [7] 102 [9] 29 [6] 53 [11] 86 [7]
Estrogen receptor status*
 Negative 267 (15) 45 (15) 55 (13) 167 (16) 24 (16) 63 (15) 180 (15)
Table 3 (continues)
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diagnostic performance (5) and reported 
wide, unexplained variability in screening 
and diagnostic performance across ra-
diologists within volume levels. We had 
expected to see the relationship between 
total interpretive volume (screening plus 
diagnostic images) or screening volume 
to be most strongly associated with 
screening performance and total volume 
or diagnostic volume to be most strongly 
mammograms within the previous 24 
months to meet continuing experi-
ence requirements. However, the reg-
ulations have no requirements about 
the indication for the examination (ie, 
they could all be screening examina-
tions or they could all be diagnostic 
examinations).
We previously examined annual in-
terpretive volume and screening (4) and 
annually work up more than 125 of 
any recalled mammograms. Despite 
variability in performance measures, 
on average, radiologists who worked 
up fewer recalled mammograms had 
consistently lower sensitivity, CDRs, 
and FPRs at any given total volume. 
Current U.S. Food and Drug Admin-
istration regulations require U.S. 
physicians to have interpreted 960 
Table 4





No. of Women Recalled 
per Cancer DetectedNo. of Reader-Years* Mean (%)† No. of Reader-Years* Mean (%)† 
Overall 380 85.3 (83.6, 86.9) 393 9.1 (8.0, 10.3) 4.1 (3.7, 4.5) 22.2
Annual volume of own  
 recalled mammograms
 0–25 mammograms 130 (34.2) 81.1 (77.4, 84.3) 141 (35.9) 6.7 (5.6, 8.0) 3.1 (2.7, 3.5) 17.4
 26–50 mammograms 85 (22.4) 84.6 (80.4, 88.0) 86 (21.9) 8.6 (7.2, 10.3) 4.0 (3.3, 4.8) 21.3
 .50 mammograms 165 (43.4) 87.0 (84.9, 88.8) 166 (42.2) 10.3 (8.7, 12.1) 4.5 (4.1, 5.0) 24.6
Annual volume of any  
 recalled mammograms 
 0–50 mammograms 94 (24.7) 80.8 (76.4, 84.7) 105 (26.7) 7.0 (5.1, 9.4) 2.9 (2.5, 3.4) 18.1
 51–125 mammograms 103 (27.1) 84.7 (81.3, 87.5) 104 (26.5) 7.6 (6.5, 8.8) 3.9 (3.3, 4.6) 18.8
 .125 mammograms 183 (48.2) 86.5 (84.3, 88.3) 184 (46.8) 10.3 (8.8, 11.9) 4.4 (4.0, 4.9) 24.6
* Numbers in parentheses are column percentages. Thirteen reader-years were not associated with any cancers and did not contribute to the sensitivity estimate.
† Numbers in parentheses are 95% CIs.




Average Annual Volume of Own Recalled  
Screening Mammograms



















(n = 1742 
 Positive 1475 (85) 260 (85) 358 (87) 857 (84) 122 (84) 352 (85) 1001 (85)
 Unknown 219 [11] 43 [12] 47 [10] 129 [11] 32 [18] 86 [17] 101 [8]
Progesterone receptor status*
 Negative 432 (25) 83 (27) 81 (20) 268 (26) 38 (27) 109 (26) 285 (24)
 Positive 1297 (75) 220 (73) 332 (80) 745 (74) 104 (73) 306 (74) 887 (76)
 Unknown 232 [12] 45 [13] 47 [10] 140 [12] 36 [20] 86 [17] 110 [9]
Note.—Numbers in parenthese are column percentages. Percentages in brackets (for unknown variables) were not included in total column percentages. There were 3101 cancers total (2646 
screening-detected cancers and 455 interval cancers). Screening-detected cancers were based on the radiologist’s initial assessment of the screening mammogram (positive or negative) linked to 
cancer diagnosis: invasive carcinoma or DCIS diagnosed within 1 year of screening mammography or before the subject’s next screening mammography examination (13).
* Invasive cancers only.
† Defined as in reference 12.
Table 3 (continued)
Characteristics of Screening-detected Tumors according to Average Annual Volume of Own and Any Recalled Screening 
Mammogram
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worked up the examinations. However, 
these findings suggest new approaches 
to organizing clinical work, and track-
ing screening and diagnostic volume 
may be worthwhile given the potential 
to improve interpretative performance.
Increasing the minimum number of 
interpretations might cause some radi-
ologists with lower annual volumes to 
stop interpreting mammograms. Con-
versely, these findings may motivate 
those radiologists to increase their vol-
umes. Workforce issues may also be less 
relevant today with the increasing use 
of digital mammography, which allows 
radiologists to interpret examinations 
or diagnostic examinations is most 
strongly associated with screening per-
formance (4,5), we chose to investigate 
the total number of examinations rather 
than proportions because tracking ex-
amination numbers might be more 
practical for practices and radiologists. 
Tracking proportions requires more 
robust data collection, including total 
numbers of examinations according to 
type and proportion. Many mammogra-
phy facilities cannot provide complete 
data volume according to interpretation 
type (screening vs diagnostic). Facilities 
also might not be able to link recalled 
mammograms with the radiologist who 
Figure 1
Figure 1: (a–c) Graphs show multivariable adjusted screening 
performance measures according to work-up of own recalled screen-
ing mammograms. Data were adjusted for age and time since last 
mammography examination. Estimated mean adjusted performance 
is presented graphically, along with pointwise 95% CIs, with curves 
being interpreted directly as mean adjusted performance as a function 
of exposure measure. Solid lines = regression spline fit to adjusted 
rates, dashed lines = 95% CIs. Circle size is proportional to number of 
screening mammograms used to measure performance. P values for 
estimated curves correspond to omnibus tests of whether there is any 
association between mean adjusted performance and exposure.  
P values are as follows: sensitivity, P = .039; FPR, P = .004; CDR,  
P < .001 (Fig 1 continues).
associated with diagnostic performance. 
Instead, the composition of interpretive 
volume (ratio of screening volume relative 
to total volume) was the greatest impor-
tant factor influencing screening and di-
agnostic performance. Radiologists with 
higher annual volumes had clinically and 
significantly lower FPRs than their lower-
volume colleagues but similar sensitiv-
ities (4,5). These earlier findings (4,5), 
combined with these current findings, 
suggest that increasing the current U.S. 
Mammography Quality Standards Act re-
quirements for interpretive volume and 
requiring a minimum number of diagnos-
tic work-ups for a radiologist’s recalled 
screening mammograms could improve a 
radiologist’s screening performance.
Despite previous findings suggest-
ing that the proportion of screening 
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remotely. Our data support a minimum 
annual interpretive volume coupled 
with annual work-up of at least 50 of 
a radiologist’s own recalled mammo-
grams. This recommendation would 
require changes in how facilities cap-
ture and report current Mammography 
Quality Standards Act interpretation 
requirements and may require some 
facilities to reorganize their workflow. 
In addition, in the absence of a national 
reporting registry, tracking interpretive 
requirements across facilities, particu-
larly if volume requirements span mul-
tiple years, would be challenging. An al-
ternative would be to have radiologists 
review the work-up of a portion of their 
own recalled mammograms (category 
0), even if they were not the radiologist 
that performed the work-up.
A common assumption is that im-
provements in sensitivity come at the 
expense of specificity, and vice versa, 
as reflected in traditional receiver op-
erating curve analysis. However, this is 
not always the case. It is possible to im-
prove both measures to the point where 
improvements in one measure reach a 
threshold beyond which the other is di-
minished (20). Thus, increases in FPRs 
associated with the improvement in 
sensitivity and CDRs potentially could 
Figure 1 (continued)
Figure 1: (continued) (d–f) Graphs show multivariable adjusted 
screening performance measures according to work-up of any recalled 
screening mammograms. Data were adjusted for age and time since 
last mammography examination. Estimated mean adjusted performance 
is presented graphically, along with pointwise 95% CIs, with curves 
being interpreted directly as mean adjusted performance as a function 
of exposure measure. Solid lines = regression spline fit to adjusted 
rates, dashed lines = 95% CIs. Circle size is proportional to number 
of screening mammograms used to measure performance. P values 
for estimated curves correspond to omnibus tests of whether there is 
any association between mean adjusted performance and exposure. 
P values are as follows: sensitivity, P = .15; FPR, P = .011; CDR, P = 
.001.
be reduced with use of other strategies 
to improve interpretative performance, 
such as interventions for radiologists 
to improve interpretative performance 
(21–23), application of performance 
thresholds (20), providing additional 
audit feedback by reviewing the lesion 
that was sampled for biopsy, or pro-
viding additional feedback related to 
improving specificity (24–27). Some 
women who undergo screening mam-
mography may regard the small increase 
in the FPR as an acceptable trade-off 
for improved sensitivity (28–31).
Disentangling the factors that in-
fluence interpretive performance (for 
mammography or any technology) re-
quires in-depth longitudinal examina-
tions on large populations that enable 
cause and effect to be established. 
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Figure 2
Figure 2: (a–c) Graphs show multivariable adjusted screening 
performance measures according to total volume in terms of low (0–50 
mammograms; solid line) and high (51 mammograms; dashed line) 
volume of own work-ups. Data are adjusted for age and time since last 
mammography examination. Plotted lines represent estimated mean 
adjusted performance as a function of total volume and according to 
radiologists with low (0–50 mammograms) and high (51 mammo-
grams) volumes of own work-ups. Circle size is proportional to number 
of screening mammograms used to measure performance. P values 
correspond to omnibus tests of whether there is difference in shape 
(interaction term to assess effect modification) of volume-performance 
association according to low versus high volumes of work-up of recalled 
screening mammograms. P values are as follows: sensitivity, P = .36; 
FPR, P = .09; CDR, P = .039 (Fig 2 continues).
clinical improvements in performance 
with these newer technologies (32–37). 
In addition, during the study period 
computer-assisted detection was not 
commonly used in the BCSC (only 29% 
of screening mammograms). This was 
not a trial where we manipulated work-
up volumes to test whether changing 
the composition would improve an in-
dividual radiologist’s performance. Our 
analysis did not include double-reading 
for screening or diagnostic mammo-
grams; however, only 3% of radiologists 
reported double-reading for 20% or 
more of their screening mammograms. 
Instead of prespecifying the categories 
for exposure distribution, our cutpoints 
were determined after examining the 
data. We took this approach to address 
feasibility for measurement, implemen-
tation, and policy. For example, with re-
calls in the range of 10% and minimum 
interpretive volume being 980 mammo-
grams during a 2-year period, it would 
be reasonable for a radiologist to be 
eligible to review 50 recalled screen-
ing mammograms. We also picked 
cut-off values that we thought would 
be feasible for implementation rather 
than basing them only off the variable 
distribution–in other words, at standard 
intervals (eg, 50 vs 53 mammograms). 
Current Mammography Quality Stan-
dards Act requirements had no sup-
porting evidence when they were estab-
lished to support the specifics of their 
requirements; they were a well-inten-
tioned judgment call. Years later, we 
now have evidence demonstrating that 
the combination of higher volume and 
direct involvement in working up one’s 
own recalled screening mammograms 
is associated with a higher sensitivity 
and CDR.
Our study had limitations. Mam-
mography performance was derived 
from examinations performed between 
2002 and 2006, when computer-assist-
ed detection and digital mammography 
were not as ubiquitous as they are now; 
however, few studies have shown large 
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Figure 2 (continued)
Figure 2: (continued) (d–f) Graphs show multivariable adjusted screening 
performance measures according to total volume in terms of low (0–125 
mammograms; solid line) and high (126 mammograms; dashed line) vol-
ume of any work-ups. Data are adjusted for age and time since last mam-
mography examination. Plotted lines represent estimated mean adjusted 
performance as a function of total volume and according to radiologists with 
low (0–125 mammograms) and high (126 mammograms) volumes of 
any work-ups. Circle size is proportional to number of screening mammo-
grams used to measure performance. P values correspond to omnibus tests 
of whether there is difference in shape (interaction term to assess effect 
modification) of volume-performance association according to low versus 
high volumes of work-up of recalled screening mammograms. P values are 
as follows: sensitivity, P = .92; FPR, P = .63; CDR, P = .47.
Finally, given the small number of 
breast imaging specialists, we could not 
examine the influence of own recalled 
mammograms and specialty training. 
We also had no information on how ra-
diologists collaborate during the work-
up process and therefore could not ex-
amine how these interactions affected 
performance metrics.
Results of our analyses suggest that 
radiologists’ screening performance 
could improve with work-up of more 
than 50 of their own recalled screen-
ing mammograms. Our findings sup-
port the BI-RADS strong recommen-
dations to track all recalled screening 
mammograms, for separate auditing for 
screening and diagnostic examinations, 
and for more extenstive auditing. This 
study, combined with previous inves-
tigations (4,5), supports an increase 
in annual volume requirements and a 
minimum diagnostic volume of recalled 
screening cases for U.S. radiologists 
who interpret mammograms.
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